These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 27811836

  • 1. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.
    MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW.
    MMWR Morb Mortal Wkly Rep; 2016 Nov 04; 65(43):1189-1194. PubMed ID: 27811836
    [Abstract] [Full Text] [Related]

  • 2. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2013 Mar 22; 62(RR-2):1-28. PubMed ID: 23515099
    [Abstract] [Full Text] [Related]

  • 3. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
    Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, MacNeil JR.
    MMWR Recomm Rep; 2020 Sep 25; 69(9):1-41. PubMed ID: 33417592
    [Abstract] [Full Text] [Related]

  • 4. Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Jan 28; 60(3):72-6. PubMed ID: 21270745
    [Abstract] [Full Text] [Related]

  • 5. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Aug 05; 60(30):1018-9. PubMed ID: 21814165
    [Abstract] [Full Text] [Related]

  • 6. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Mar 12; 59(9):273. PubMed ID: 20224545
    [Abstract] [Full Text] [Related]

  • 7. Meningococcal conjugate vaccines policy update: booster dose recommendations.
    Committee on Infectious Diseases.
    Pediatrics; 2011 Dec 12; 128(6):1213-8. PubMed ID: 22123893
    [Abstract] [Full Text] [Related]

  • 8. Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2013 Jan 25; 62(3):52-4. PubMed ID: 23344698
    [Abstract] [Full Text] [Related]

  • 9. Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Collins JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, Campos-Outcalt D, Loehr J, Morgan RL, Poehling KA, McNamara LA.
    MMWR Morb Mortal Wkly Rep; 2024 Apr 18; 73(15):345-350. PubMed ID: 38635488
    [Abstract] [Full Text] [Related]

  • 10. Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.
    MacNeil JR, Rubin L, McNamara L, Briere EC, Clark TA, Cohn AC, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
    MMWR Morb Mortal Wkly Rep; 2014 Jun 20; 63(24):527-30. PubMed ID: 24941332
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2005 May 27; 54(RR-7):1-21. PubMed ID: 15917737
    [Abstract] [Full Text] [Related]

  • 13. Prevention of meningococcal infections in the first 2 years of life.
    Woods CR.
    Pediatr Ann; 2013 Aug 27; 42(8):164-71. PubMed ID: 23910030
    [Abstract] [Full Text] [Related]

  • 14. Recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MenACWY-D) among children aged 9 through 23 months at increased risk for invasive meningococcal disease.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Oct 14; 60(40):1391-2. PubMed ID: 21993344
    [Abstract] [Full Text] [Related]

  • 15. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231
    [Abstract] [Full Text] [Related]

  • 16. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
    Abdelnour A, Silas PE, Lamas MR, Aragón CF, Chiu NC, Chiu CH, Acuña TH, Castrejón Tde L, Izu A, Odrljin T, Smolenov I, Hohenboken M, Dull PM.
    Vaccine; 2014 Feb 12; 32(8):965-72. PubMed ID: 24397906
    [Abstract] [Full Text] [Related]

  • 17. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
    Baxter R, Reisinger K, Block SL, Izu A, Odrljin T, Dull P.
    J Pediatr; 2014 Jun 12; 164(6):1409-15.e4. PubMed ID: 24657122
    [Abstract] [Full Text] [Related]

  • 18. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW.
    MMWR Morb Mortal Wkly Rep; 2015 Oct 23; 64(41):1171-6. PubMed ID: 26492381
    [Abstract] [Full Text] [Related]

  • 19. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 20. Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine--United States, March 1, 2010-September 22, 2015.
    Su JR, Miller ER, Duffy J, Baer BM, Cano MV.
    MMWR Morb Mortal Wkly Rep; 2016 Feb 19; 65(6):161-2. PubMed ID: 26890604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.